chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe, itching rash on arms, back legs & shoulder. Saw Dr on 6/9/21 because the rash was getting worse & more intense. The rash was similar looking to Shingles, not the severe pain but severe itching. I received a dermatological steroid injection & was prescribed Triamcinolone Acetonide Cream USP, 0.1%. The itching did not begin subsiding until much later that evening. My appointment with  Dermatology was at 7:45 am on on 6/9/21.
grandmother stated p/pt recvd last vax pt screamed & cried unconsolable from about 430-5PM until p/midnight 2JAN96;states almost took pt to ER, but did not;
Swelling of left thigh around shot area Measuring 16.5cm X 11cm with an area close to inner thigh measuring 13cm X 6.5 cm started the morning after shots and increased in size, he limps on that leg.  No fever.  Treated with warm compresses, ibuprofen and Benadryl.
A consumer report has been received. The report concerns a 26 year old, female consumer, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. The reporter reported that she received FLUMIST QUADRIVALENT last week and found out she was pregnant last night which started on 22-Sep-2013. The outcome of the event of received FLUMIST QUADRIVALENT last week and found out she was pregnant last night is unknown. The report was considered to be non-serious.
After receiving the second dose of Moderna COVID vaccine, I started having Eczema flare-ups and my Eczema spread to my groin, knees, arms, back, and face. It is still ongoing with no changes around the time of the vaccine. No course of medical action has kept it at bay. I believe it was the COVID vaccine because it is the only change in my life at the time the chronic Eczema flare-ups started.   Treatments tried: hydracortisone 2.5%, 0.05% Clobetasol mixed in Cetaphil moisturizing cream, Permethrin 5% cream (to rule out mites), triamcinolone acetonide, singulair, Ketoconazole 2% Cream, Hydroxyzine HCL 25mg tab, cortisone shot, UV therapy (one tried. Am restarting UV therapy in the near future), citrizine, None of these things have resulted in Eczema not being chronic.
cellulitis in lt arm approx size of fifty cent piece;area red, warm to touch;inflamed c/o pain in area; tx warm pack, ATB & seek care if redness, Ibuprofen;
soreness on right side of neck and behind ear; soreness on right side of neck and behind ear; redness around site of injection; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (soreness on right side of neck and behind ear), EAR PAIN (soreness on right side of neck and behind ear) and VACCINATION SITE ERYTHEMA (redness around site of injection) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced NECK PAIN (soreness on right side of neck and behind ear), EAR PAIN (soreness on right side of neck and behind ear) and VACCINATION SITE ERYTHEMA (redness around site of injection). At the time of the report, NECK PAIN (soreness on right side of neck and behind ear), EAR PAIN (soreness on right side of neck and behind ear) and VACCINATION SITE ERYTHEMA (redness around site of injection) outcome was unknown.            Concomitant Medications were not provided  by the reporter. Treatment History includes ibuprofen.
Hospitalization for Covid019 Pneumonia, elevated procalcitonin with concern for underlying bacterial pneumonia, acute on chronic hypoxic respiratory failure, severe sepsis due to pneumonia with hypertension on dates 9/10/2023- 9/19/2023. Treated with dexamethasone, baricitinib, Remdesivir.
Information has been viewed on the internet concerning a 15 month old female who was vaccinated with a dose of MMR II. Concomitant vaccination included a dose of DTaP (unspecified). It was reported that the patient was injured by the MMR II vaccine and DTaP vaccine (unspecified). It was stated that the patient experienced brain inflammation, immune system malfunction and CNS disorders. Attempts to verify the existence of an identifiable patient have been unsuccessful. Additional information is not expected.
At ~ 5:30 pm, while driving my vision suddenly went, for lack of a better term, haywire.  Perhaps ?Vertigo?.  Vision was such that I had to pull over so as not to cause an accident.  It was as if each eye was looking at the same view differently and all jumbles.  Perhaps like looking through a prism and seeing multiple views of the same image ,  Able to stabilize it by covering one eye and viewing with the other, and vice versa.  Was able to drive again approximately 2-3 minutes away by keeping left eye closed; and able to see ok with one eve.  When stopped and opened other eye the incident stabilized and went away.  Was able to get out of vehicle and walk ok. The following day, experienced feverish symptoms throughout the day and had 101 degree fever by 9:30 pm.  Temperature settled down to 99 by 11 pm after resting.  That is the extent of the symptoms other that a slightly sore arm at the injection site which was fine by the next day.
shortness of breath, palpitations, 10 mins after vaccine given. Monitored for 30mins, vitals stable, taken to urgent care for further monitoring
pt recv vax 28AUG92 & w/in 24hr exp pain in hand & feet, migratory pain in multiple joints, fatigue, fibromyalgia, polyarthritis, stiffness, alopecia, weakness, arthralgia, swelling of MP & PIP joints, vascular problem, arthropathy;
infant received Havrix adult dose; infant received Havrix adult dose; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 1-year-old male patient who received HAV (Havrix) (batch number 2BA99, expiry date 16th December 2022) for prophylaxis.   On 29th August 2022, the patient received Havrix. On 29th August 2022, unknown after receiving Havrix, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.   Additional Information: GSK Receipt Date: 31-AUG-2022 Reporter's comment: The reporter stated that an infant patient was administered an adult dose of Havrix. The vaccine administration facility was the same as primary reporter. The reporter did not answer if follow up was ok but did not decline. Additional Supportive Information: The patient was administered an adult dose of Havrix, which led to overdose and adult product administered to child.
c/o feeling dizzy and diaphoretic a few minutes after receiving vaccine. Was pale and clammy to touch. Laid down and given water and candy. Felt better after 15 minutes and discharged back to work.
11 Days After Vaccination, Patient began developing urticaria, first in the left axillary region. This spread to the rest of the body over the following couple of days. The rash was red, raised, and itchy. The patient also noted pronounced dermatographism at that time. Three days after the rash appeared, the patient reported swelling of the joints, specifically knees and fingers. Additionally around that time patient expressed a feeling of throat tightness, although retrospectively this has been identified to be more representative of acid reflux. During the first few days, the patient took OTC Benadryl. Patient presented to urgent care on February 18 and was given a cortisone injection, an epipen prescription, and advised to start taking Zyrtec OTC. Joint swelling did resolve but rash and itching persisted. On February 28, patient presented to her primary care physician, Dr, who noted the continued diffuse, intermittent, rash which was extremely responsive to contact with the skin. At this time, idiopathic urticaria was expected and the link was not yet made to the COVID vaccine. The PCP ran a blood allergy panel, suggested patient take zyrtec twice daily and add in pepcid twice daily, prescribed montelukast, and referred to an allergist. The rash responded well to the medication regimen. The blood allergen test was unremarkable. In anticipation of the skin test with the allergist, the patient was advised to stop all antihistamines for three days prior. This cessation of medication resulted in an extreme flare up of the rash, with full body itching, including the scalp, palms, and soles. These symptoms were not tolerable and the extreme irritability of the skin was not conducive to allergy skin testing, so the patient resumed zyrtec and pepcid with much relief. The allergist, Dr, immediately identified the rash as a possible reaction to the Moderna Booster, noting that he had seen a similar reaction in many patients. He agreed with the medication regimen prescribed by the PCP and predicted that the reaction would subside naturally within three months or so. He recommended follow up at that time. Fast forward three months, on May 19, the rash persists although is much more mild. If the patient misses a dose of her twice daily medication regimen, the rash flares up.
Case contracted Covid, was hospitalized for, and died from Covid after being vaccinated for Covid.  Case was admitted to hospital with Covid pneumonia, and was intubated on 9/26/21. Her health did not improve, and when she was extubated on 10/15, she died that day.
Mild to moderate headache 6/10, pain in right arm, nothing like the first reaction, tolerable, nausea, inability to sleep, very off right leg pain in the hip area that is still there,  I called Dr. this AM and started steroid pack for headache, butalbolat to start taking agian and I took a zofran for my stomach.
Vaccine that was administered was expired with expiration date of 6/30/2020. The patient did not have any symptoms or adverse effects.
10 minutes after vaccine started to feel clammy and passed out sitting in chair for approximately 30 seconds, woke up and was sweaty
I had chills, feverish, runny nose, congestion, minor body aches,  and fatigued. I didn't have a cough, but I had a minor sore throat. I am still dealing with this at this time.
tested positive for covid; tested positive for covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old male patient received bnt162b2 (BNT162B2), administration date 25Oct2021 (Batch/Lot number: unknown) at the age of 50 years as dose 2, single and administration date 20Sep2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation at facility. The patient had no relevant medical history. There were no concomitant medications. The patient had no known allergies.  The following information was reported: VACCINATION FAILURE (medically significant) with onset 03Jan2022, outcome "unknown", COVID-19 (medically significant) with onset 03Jan2022, outcome "recovered" (Jan2022) and all described as "tested positive for covid". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (04Jan2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of covid-19. Clinical course: The patient did not receive any other vaccine within 4 weeks. The patient did not receive any other medications within 2 weeks. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was tested for COVID-19 post vaccination and resulted positive on 04Jan2022 under quick test (nasal swab test type).  The lot number for bnt162b2 was not provided and will be requested during follow up.
At 1000, KINRIX by SKB AC20B213AA expires 08/29/2014 0.5 ml IM was given in the RVL and MMRV PROQUAD MSD H017885 expires 4/1/2014 0.5ml was given in the left lateral thigh SQ, by APN, CPNP. Child did not cry after either immunization. After the first immunization of DTaP/IPV child states "that felt weird". Almost immediately after completion of the MMRV injection, child slumped, hands were fisted and pulled toward face in a decorticate manner, elbows bent, eyes veered off to the left, face flushed but no cyanosis. Child was laid flat on exam table and immediately came to. Event lasted less than 1 minute. Child then voided and began crying. He did report pain at his injection sites and a faint rash was noted around the injection site of the left thigh. VS- pulsox 100% on RA, pulse 106 and blood pressure 116/85. Child continues to cry and complain of pain. Child and mother instructed to remain in room for observation. Dr. notified. VAERS form completed. 1015- Mother states child continues to cry and say he feels "weird" and try to remove his clothes. At this point another set of VS taken- pulsox 99% RA, heart rate 113, respiratory 34 blood pressure 119/61. It was decided to transport child to hospital for further evaluation via ambulance and 911 called. 1020- ambulance arrives and child transported without incident. He is awake and alert during this time. No rash is still noted. Dr. on call called and informed of events. Filled in on history and described incident in detail. She states that it sounds like a vasovagal response. 1300- Emergency Room called and spoke with Dr. who states child was discharged home after all scans and blood work negative and child doing much better.
Information has been received from a certified medical assistant, who is the grandmother, concerning her grandson, a 5 year old white male student who has an allergy to red dye, and who on 30DEC1998 was vaccinated SC with a first dose of varicella virus vaccine live. The certified medical assistant reported that the lot number and site of administration were not recorded. There was no concomitant medication. Also, it was noted that the pt had not received any other vaccinations on the same day. The certified medical assistant reported that on 21SEP2003 (also reported as 22SEP2003 by nurse practitioner) here grandson developed chicken pox even though he  was immunized with varicella virus vaccine live. She described that on 21SEP2003 her grandson developed an itchy rash, that spread and then blistered. At the onset, he also had a low grade fever. The certified medical assistant reported the rash distribution was especially on one leg, but she indicated that she did not know which leg, nor if it was the same leg used for varicella virus vaccine live administration. The certified medical assistant reported that "this case" was not as sever as others that the she has seen. The pt was prescribed cetririzine hydrochloride, Zyrtec, and calamine + camphor + pramoxine hydrochloride AVEENO baths for itching and a decongestant for nasal congestion. It was noted that as of today, 08OCT2003, the rash has cleared completely. It was noted that the adverse event abated and the pt recovered. There was no product complaint reported.  Follow up information was received form a nurse practitioner who reported that the pt's chickenpox were on his back, neck, lower legs, and arms for one week. Additionally, it was reported that the pt also had a low grade fever and slgiht cough, and he was out of school for one week. Subsequently, the patient recovered. The nurse practitioner reported that there were no relevant laboratory or diagnostic tests performed, and the patient did not have an illness at the time of vaccination. The nurse practitioner also reported that the patient did not develop a rash at the injection site or elsewhere within 42 days of varicella virus vaccine live administration. Unspecified medical attention was sought. Further information is not expected.
Pt recvd vax & w/in 4 hrs exp sore throat, nasal congestion & elevated temp (100) for 24 hrs; did not receive treatment;
Tightness in chest, sweats, chills, nausea, vomiting, SOB, fatigue
More than 36 days have passed since getting first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days have passed since getting first dose) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days have passed since getting first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days have passed since getting first dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-May-2021, Antibody test: 250.00 (Positive) came out greater than 250.00 and it was positive. On 04-May-2021, SARS-CoV-2 test: (Negative) negative. On 03-Aug-2021, Antibody test: 3110.2 (Positive) came back as positive again. On 03-Aug-2021, SARS-CoV-2 test: (Negative) negative.         No treatment medications were provided.   This case was linked to MOD-2021-037732 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: dose 2 regimen added in product tab, action taken changed to not applicable On 09-Aug-2021: Date of dose 2 vaccination was updated.; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273, lot #: 037K20A with no associated AEs.
My appendix burst. I  would not associate appendicitis as an adverse vaccine effect, except I read on the CDC website that a study of the Pfizer vaccine (I had Moderna) resulted in "The most common serious adverse event occurring at higher rates i the vaccine group than the placebo group was appendicitis."   My burst appendix resulted in severe infection, three total weeks of hospitalization, and the removal of part of my colon  I want to be sure that the relationship between the vaccine & appendicitis is being followed.
This spontaneous report as received from a physician refers to a 6 month old male patient who on 17-MAY-2013, was vaccinated with a dose of VAQTA (dose, route and lot number not reported). Additional information has been requested.
ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 8/3/2022 CANCER PAIN MGMT  ACUTE RESPIRATORY FAILURE 7/18/2022 CANCER PAIN MGMT  ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/28/2022 CANCER PAIN MGMT  ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 8/3/2022 ANEMIA OF CHRONIC DISEASE  ACUTE RESPIRATORY FAILURE 7/18/2022 ANEMIA OF CHRONIC DISEASE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/28/2022 ANEMIA OF CHRONIC DISEASE  ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 8/3/2022 ANEMIA OF CHRONIC DISEASE  ACUTE RESPIRATORY FAILURE 7/18/2022 ANEMIA OF CHRONIC DISEASE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/28/2022 ANEMIA OF CHRONIC DISEASE  ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 8/3/2022 PRESENCE OF INFERIOR VENA CAVA FILTER  ACUTE RESPIRATORY FAILURE 7/18/2022 PRESENCE OF INFERIOR VENA CAVA FILTER  ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/28/2022 PRESENCE OF INFERIOR VENA CAVA FILTER  ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 8/3/2022 ADHD, PREDOMINANTLY INATTENTIVE PRESENTATION  ACUTE RESPIRATORY FAILURE 7/18/2022 ADHD, PREDOMINANTLY INATTENTIVE PRESENTATION  ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/28/2022 ADHD, PREDOMINANTLY INATTENTIVE PRESENTATION  ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 8/3/2022 METABOLIC ENCEPHALOPATHY  ACUTE RESPIRATORY FAILURE 7/18/2022 METABOLIC ENCEPHALOPATHY  ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/28/2022 METABOLIC ENCEPHALOPATHY
2-1/4" by 1-3/4" red rash, itching on underside of left arm, 2 " from wrist
achy at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 57-year-old female patient who received Herpes zoster (Shingrix) (batch number B327C, expiry date 4th July 2020) for prophylaxis.   On 30th April 2018, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient arm was achy at the injection site for a day or two after receiving the first dose of the Shingrix vaccine. The reporter was unable to provide any additional information. This case has been linked with cases US2019AMR126801 and US2019125917, reported by the same reporter.
Client presented to clinic for 2nd MMR upon asking screening questions, she said she did not do well with her 1st MMR vaccine.  States her brother told her that she "broke out in the hives and swelled up" Referred pt for MMR medical or to his private doctor. client will not return my calls to complete this form.
2/23/21 - About 20 minutes following vaccination, tingling in the face around the mouth and lips began.  Lips felt thick and looked slightly swollen.  Symptoms seemed isolated to general area of the mouth.  Tingling lasted for about an hour.  Gradually decreasing over the next 2 hours.  Lips remained feeling thick. 2/24/21 - Upon waking in AM, lips were chapped and peeling.  Felt tender all day. 2/25/21 - Upon waking in AM, lips only slightly chapped, no peeling, slightly less thick. 2/26/21 - Lips seemed to be of normal thickness.
This is a spontaneous report from a contactable consumer. This male consumer (Patient) of unknown age reported that he received dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 17Mar2021 as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 18Mar2021 the patient experienced nosebleed. He stated that this phone number was on his paperwork from yesterday when he got his Covid 19 vaccine shot and he was bleeding from his nose about 40 minutes ago. He had never bled from his nose before, and it was not listed on his paperwork as a side effect. He was worried and wanted to know what to do. The event outcome was unknown.  No follow-up attempts were possible; information about lot/batch number could not be obtained.
After the first dose on Sept 17, I had a (menstrual) migraine the next day and my period which had consistently been coming the 25th-27th) came Sept 19 (about a week early.)  I received the second dose Oct 8 and on Oct 12 (only about 3 weeks from the start of the previous period on Sept 19) my period started again and I had very heavy bleeding, which I haven't had since before I went on birth control about 15 years ago.  I contacted my OB/GYN and they asked for me to monitor my cycle going forward.
vaccinated with an expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 50-year-old female patient who received Herpes zoster (Shingrix) (batch number GB429, expiry date 5th December 2021) for prophylaxis.   On 9th December 2021, the patient received Shingrix. On 9th December 2021, unknown after receiving Shingrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The patient received an expired dose of Shingrix, which led to expired vaccine used. The reporter consented to follow up.
Fever - max temp 103.7, loss of appetite, erythematous papular rash on trunk, buttocks, limbs.
Shooting pain in left arm that is inconsistent with any medical condition other than the vaccine.  Lasting from onset to present.  Limits activities. Flares up upon exertion of deltoid muscle.  Very unusual because I do not usually have pain or complain of pain.